Dietary supplement makers push FDA on peptides and probiotics
WASHINGTON (AP) — Makers of dietary supplements are pushing the Food and Drug Administration to expand the types…
Children’s ibuprofen recall: FDA issues notice for Taro Pharmaceuticals’ product
WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of…
FDA approves high-dose Wegovy shots
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help…
Top FDA official seeks to hire friend pushing new antidepressants warning
WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
FDA plans bonuses to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA drug approvals: Makary and Prasad say one study will be enough
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
Indian Health Service to end use of mercury dental fillings
ALBUQUERQUE, N.M. (AP) — The federal agency that provides health care to Native Americans and Alaska Natives has…
Hims & Hers cancels plan for Wegovy weight-loss pill knockoff
Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy…
Merck’s experimental pill enlicitide sharply lowered cholesterol in a large study
WASHINGTON (AP) — A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high…
FDA’s drug voucher program: House lawmaker raises new concerns
WASHINGTON (AP) — A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed…
FDA commissioner’s drug review plan sparks alarm
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
Takeaways on turmoil surrounding FDA fast-track drug program
WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking…